Evidence mapPaperPMID 41345805Full record

ArticleEuropean journal of pediatrics2025

The triglyceride glucose index as a biomarker for different glucose disorders in overweight and obese children and adolescents.

Ola Taha, Lobna Abdallah, Adel Erfan, Radwa Elsharaby, Doaa El Amrousy

Abstract read
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ola TahaPediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Lobna AbdallahMinistry of Health and Population, Tanta, Egypt.
Adel ErfanPediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Radwa ElsharabyClinical Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Doaa El AmrousyPediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt. Doaa.moha@med.tanta.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The triglyceride/glucose index (TyG index), a formula derived from fasting triglyceride (TG) and glucose levels, has emerged as a simple and reliable alternative marker for estimating insulin resistance (IR). This study aimed to evaluate the potential utility of the TyG index in predicting different glucose disorders (GD) in obese and overweight children. This prospective study included 60 children aged 5 to 15 years with overweight or obesity. They were divided into two equal groups: Group 1 consisted of children with obesity (BMI > 95th percentile), and Group 2 comprised overweight children (BMI 85th-95th percentile). The control group consisted of 30 healthy children with normal BMI, matched for age and sex. TG, fasting blood glucose (FBG), oral glucose tolerance test, 2-h postprandial glucose, the TyG index, homeostatic model assessment for IR (HOMA-IR), and glycated hemoglobin (HbA1c) were measured in all participating children. TG, HbA1c, FBG, and the TyG index were significantly elevated in both groups 1 and 2 compared with the control group. There was a strong positive correlation between TyG index and (HbA1C, FBG, HOMA IR, and 2-h postprandial glucose). The TyG index demonstrated a strong predictive ability for type 2 diabetes, impaired glucose tolerance, impaired fasting glucose, and IR with cut-off values of 4.57, 4.52, 4.43, and 4.34, respectively. These cut-off values were associated with sensitivities of 100%, 100%, 88.9%, and 71.4%, and specificities of 95.3%, 95.1%, 88.3%, and 100%, respectively.

conclusionThe TyG index is a promising and reliable marker for detecting different glucose disorders in obese and overweight children. WHAT IS KNOWN: • The triglyceride/glucose index (TyG index), a formula derived from fasting triglyceride (TG) and glucose levels, has emerged as a simple and reliable alternative marker for estimating insulin resistance (IR) in pediatrics and adults. WHAT IS NEW: • We investigated, for the first time, the potential utility of the TyG index in predicting different glucose disorders (GD) such as type 2 diabetes mellitus (T2DM), impaired glucose tolerance, impaired fasting glucose as well as IR in obese and overweight children. • We found that the TyG index is a promising and reliable marker for detecting different glucose disorders in obese and overweight children.

Indexed as

Blood GlucoseGlucose Metabolism DisordersOverweightPediatric ObesityTriglyceridesAdolescentBiomarkersCase-Control StudiesChildChild, PreschoolFemaleGlucose Tolerance TestGlycated HemoglobinHumansInsulin ResistanceMaleBiomarkersBlood GlucoseGlycated HemoglobinTriglyceridesChildhoodImpaired fasting glucoseImpaired glucose toleranceInsulin resistanceObesityTyG indexType 2 DM

Identifiers

PMID41345805
PMCPMC12678614

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.